Market Tracker

07/30 11:10am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

50.56
Real-Time Quote
 -0.53 / -1.04%
Today’s Change
36.82
Today|||52-Week Range
80.42
-3.88%
Year-to-Date

Today’s Trading

Previous close51.09
Today’s open51.69
Day’s range50.13 - 52.40
Volume65,770
Average volume (3 months)304,088
Market cap$1.1B
Dividend yield--
Data as of 10:55am ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio108.7
Price/Sales21.82
Price/Book21.08

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.24+0.83%
NBIXNeurocrine Bioscienc...+0.15+1.09%
ARNAArena Pharmaceutical...+0.03+0.64%
RCPTReceptos Inc+0.17+0.42%
Data as of 11:10am ET, 07/30/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)$0.12
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts